The Latest
These are challenging times for early-career oncology researchers and—by extension—the patients and families who need the treatments and cures those researchers dedicate their careers to pursuing. With grants disappearing and federal research funding in short supply, junior investigators are often among the hardest hit.
ALEXANDRIA, Virginia—Twisted Pink’s “Metastatic Breast Cancer Impact Award,” powered by Conquer Cancer’s EveryGrant®, has awarded a grant to Hanna Irie, MD, PhD, for her work studying a novel therapeutic approach targeting brain metastases in patients with triple negative breast cancer.
The Colombian Association of Hematology and Oncology (ACHO), has awarded three grants through the ACHO Defying Cancer program, powered by EveryGrant®, from Conquer Cancer, the ASCO Foundation. The ACHO Defying Cancer program supports innovative research projects from early-career and mid-career to senior investigators in the field of hematology and medical oncology in Colombia.
ALEXANDRIA, VA. — Conquer Cancer®, the ASCO Foundation, today announced the recipients of the Conquer Cancer – Breast Cancer Research Foundation Advanced Clinical Research Award in Breast Cancer Research. This award provides $450,000 in funding over three years to independent mid-career investigators who wish to conduct original, patient-oriented breast cancer research that is not currently funded.
A year ago, Dr. Suresh Ramalingam took the plenary stage at ASCO Annual Meeting to discuss incredible progress from his work on advanced lung cancer treatment. At the conclusion, he received a standing ovation.
ALEXANDRIA, Va. — Conquer Cancer®, the ASCO Foundation, will present more than $11.5 million in funding through more than 450 grants and awards spanning multiple areas of cancer care. These awards will be given in conjunction with the 2025 ASCO Annual Meeting held in Chicago, Illinois, May 30–June 3.
For PR Professionals
Media Contact:
Email: mediateam@asco.org